This Event has Passed
According to the WHO, hearing loss is the most common neurological disorder worldwide, affecting approximately 400 million people. Currently, the most frequently used treatment for hearing disorders involves hearing rehabilitation using hearing devices. Recent advances in gene therapy provided a promising treatment modality for genetic hearing loss by overcoming the functional deficits caused by the underlying genetic mutations. Thus, gene therapy is capable of restoring hearing functions.
Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.
During this webinar, we will discuss the following key points:
* Hearing loss affects ~400 million people worldwide but there is no biological treatment available
* Gene therapy for genetic hearing loss is a promising treatment modality
* The development of gene therapy to treat two forms of genetic hearing loss
